Cellectar Biosciences, Inc. Financial Ratios — CLRB Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-96.78	-79.82	-117.88	-79.58	-52.29	-53.93	-96.2	-94.82	-103.23	-42.57	-50.33	-108.15	-254.09	-237.45	-107.74
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	5.82	- -	- -	- -	33.97	9.65	14.48	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1	1	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Total Debt/EBITDA	-0.08	-0.05	-0.04	-0.05	-0.04	-0.01	- -	- -	-0.04	-0.03	-0.01	-0.02	-0.01	-0.01	-0.02
Net Debt/EBITDA	0.89	0.51	0.18	0.96	0.43	1.25	0.83	1.15	0.76	3.77	1.49	0.69	0.25	0.45	0.58
Total Debt/EBIT	-0.07	-0.05	-0.04	-0.05	-0.04	-0.01	- -	- -	-0.04	-0.03	-0.01	-0.02	-0.01	-0.01	-0.02
Net Debt/EBIT	0.8	0.48	0.17	0.93	0.41	1.2	0.74	1.14	0.75	3.74	1.48	0.69	0.25	0.45	0.57
EBITDA to Interest Expense	-32.33	-884.58	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-33	-895.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-35.64	-937.85	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-298.02	-350.9	-749.12	-440.49	-850.49	-461.92	-655.32	-648.25	-911.62	-216.12	-405.62	-741.05	-1,679.1	-970.96	-1,796.82
Long-Term Debt/Equity (%)	4.79	4.45	26.48	5.09	5.73	0.04	0.02	- -	4.65	0.55	0.5	6.78	- -	2.87	3.62
Long-Term Debt/Capital (%)	-1.46	-1.13	-0.89	-0.58	-0.15	-0.01	- -	- -	-0.38	-0.28	-0.11	-0.35	-0.25	-0.17	-0.12
Long-Term Debt/Total Assets (%)	4.3	3.94	6.6	2.54	1.25	0.03	0.02	- -	3.44	0.51	0.45	2.56	4.09	1.61	2.07
Total Debt/Equity (%)	4.81	4.47	26.58	6.92	20.65	0.7	0.05	0.02	5.82	0.77	0.91	7.41	-3.65	3.46	4.8
Total Debt/Capital (%)	-1.47	-1.14	-0.89	-0.79	-0.53	-0.14	-0.01	- -	-0.48	-0.4	-0.2	-0.38	-0.28	-0.2	-0.15
Total Debt/Total Assets (%)	4.32	3.96	6.63	3.45	4.48	0.62	0.04	0.01	4.31	0.72	0.81	2.8	4.58	1.94	2.73
Net Debt to Equity	-53.33	-41.62	-115.82	-133.97	-213.82	-83.89	-93.04	-99.96	-117.17	-104.33	-108.05	-243.66	63.1	-162.92	-154.57
Net Debt/Capital (%)	13.84	9.5	3.71	13.18	5.18	13.98	10.72	12.24	8.8	34.97	19.31	11.08	4.62	8.64	4.69
EBITDA	-6	-8	-11	-9	-8	-9	-12	-12	-14	-15	-24	-29	-39	-51	-23
EBITDA-CapEx	-6	-8	-11	-9	-8	-9	-12	-12	-14	-15	-24	-29	-40	-52	-23
Operating Income (Loss)	-6	-9	-11	-10	-9	-9	-14	-12	-14	-15	-24	-29	-39	-52	-23

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	10.93	6.38	0.53	1.51	0.68	7.01	4.73	8.17	3.83	16.04	8.95	1.73	0.38	2.48	2.78
Current Ratio	11.55	7	0.61	1.56	0.73	7.47	4.95	8.6	4.11	16.26	9.16	1.78	0.41	2.58	2.96
Quick Ratio	10.93	6.38	0.53	1.51	0.68	7.01	4.73	8.17	3.83	16.04	8.95	1.73	0.38	2.48	2.78
CFO/Avg Current Liab	-8.48	-10.65	-3.48	-1.64	-1.38	-2.26	-5.88	-6.12	-5.33	-4.4	-5.98	-3.26	-1.76	-2.74	-3.27
Common Equity/Total Assets	-298.02	-350.9	-749.12	-440.49	-850.49	-461.92	-655.32	-648.25	-911.62	-216.12	-405.62	-741.05	-1,679.1	-970.96	-1,796.82
Long-Term Debt/Equity (%)	4.79	4.45	26.48	5.09	5.73	0.04	0.02	- -	4.65	0.55	0.5	6.78	- -	2.87	3.62
Long-Term Debt/Capital (%)	-1.46	-1.13	-0.89	-0.58	-0.15	-0.01	- -	- -	-0.38	-0.28	-0.11	-0.35	-0.25	-0.17	-0.12
Long-Term Debt/Total Assets (%)	4.3	3.94	6.6	2.54	1.25	0.03	0.02	- -	3.44	0.51	0.45	2.56	4.09	1.61	2.07
Total Debt/Equity (%)	4.81	4.47	26.58	6.92	20.65	0.7	0.05	0.02	5.82	0.77	0.91	7.41	-3.65	3.46	4.8
Total Debt/Capital (%)	-1.47	-1.14	-0.89	-0.79	-0.53	-0.14	-0.01	- -	-0.48	-0.4	-0.2	-0.38	-0.28	-0.2	-0.15
Total Debt/Total Assets (%)	4.32	3.96	6.63	3.45	4.48	0.62	0.04	0.01	4.31	0.72	0.81	2.8	4.58	1.94	2.73
CFO/Total Liabilities	-551.74	-498.95	-178.93	-131.52	-138.11	-464.07	-520.56	-638.11	-366.41	-360.5	-542.96	-187.71	-118.88	-425.63	-358.91
CFO/CapEx	-50.42	-67.41	-61.93	-298.98	-140.46	-114.63	-31.79	-29.72	-476.48	-223.45	-159.65	-111.62	-37.47	-456.67	-3,931.67
Altman's Z-Score	2.35	7.38	-19.1	-7.32	-19.71	-6.83	-8.21	-9.11	-12.49	3.62	-1.48	-13.74	-34.89	-19.01	-28.76

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	16	34	21	23	6	5	19	5	17	41	37	12	34	11	8
- Cash & Cash Equivalents	6	5	2	9	4	11	10	13	11	57	36	20	10	23	13
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	1	1	3	1	20	1	- -	5	1	1
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1	1	- -	- -
Enterprise Value	11	30	19	14	3	-5	10	-6	8	5	3	-7	30	-11	-5
Total Capital	-31	-40	-51	-59	-64	-70	-83	-95	-110	-106	-149	-159	-198	-246	-268
Total Debt/Capital (%)	-1.47	-1.14	-0.89	-0.79	-0.53	-0.14	-0.01	- -	-0.48	-0.4	-0.2	-0.38	-0.28	-0.2	-0.15
Total Debt / EV	0.04	0.02	0.02	0.03	0.12	-0.02	- -	- -	0.06	0.09	0.12	-0.08	0.02	-0.04	-0.09
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	16	34	21	23	6	5	19	5	17	41	37	12	34	11	8
Diluted Enterprise Value	11	30	19	14	3	-5	10	-6	8	5	3	-7	30	-11	-5
EV per Share	181,219.11	389,149.95	201,298	57,147.14	9,902.29	- -	2,184.54	- -	325.59	68.17	14.16	- -	72.46	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-6	-8	-11	-9	-8	-9	-12	-12	-14	-15	-24	-29	-39	-51	-23
TTM Operating Income	-6	-9	-11	-10	-9	-9	-14	-12	-14	-15	-24	-29	-39	-52	-23
TTM Cash Flow to Firm	-6	-7	-9	-9	-8	-8	-11	-11	-12	-14	-23	-25	-32	-48	-23
TTM Free Cash Flow to Firm	-6	-6	-9	-9	-8	-8	-11	-11	-12	-14	-22	-25	-32	-47	-23

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.75	-5.27	-2.34	-2.65	-0.78	-0.65	-1.8	-0.42	-1.48	-2.97	-1.63	-0.48	-1.07	-0.23	-0.33
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	11	30	19	14	3	-5	10	-6	8	5	3	-7	30	-11	-5
Low Price	198,000	240,000	150,000	52,800	18,600	3,000	3,240	366	312	303	174	37.5	39	6.72	2.45
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-10.62	-4.75	-2.41	-5.19	-3.91	-1.45	-1.61	-1.36	-1.12	-2.12	-3	-0.96	-0.55	-2.16	-0.78
Price/Earnings High	-37.66	-10.88	-4.18	-8.64	-6.07	-5.74	-2.87	-2.76	-2.04	-4.37	-6.86	-1.75	-0.9	-3.66	-2.46
Price/Earnings Low	-1.62	-1.98	-1.32	-1.65	-0.97	-0.47	-1.01	-0.23	-0.57	-1.33	-1.33	-0.28	-0.37	-0.18	-0.29
Price/Book Value	-0.51	-0.85	-0.41	-0.4	-0.1	-0.08	-0.23	-0.05	-0.15	-0.33	-0.24	-0.08	-0.17	-0.04	-0.03
Price/Book Value Average	-2.51	-1.1	-0.51	-0.71	-0.33	-0.19	-0.29	-0.22	-0.14	-0.25	-0.48	-0.19	-0.12	-0.39	-0.06
Price/Book Value High	-8.89	-2.52	-0.88	-1.18	-0.52	-0.76	-0.51	-0.44	-0.26	-0.52	-1.1	-0.35	-0.19	-0.66	-0.2
Price/Book Value Low	-0.38	-0.46	-0.28	-0.23	-0.08	-0.06	-0.18	-0.04	-0.07	-0.16	-0.21	-0.06	-0.08	-0.03	-0.02
Price/Tangible Book Value	2.06	4.03	875.54	4.65	-247.45	0.48	2.38	0.43	2.18	1.19	1.16	1.48	-1.71	0.79	0.96
Price/Tangible Book Value Average	10.12	5.23	1,077.8	8.32	-838.19	1.23	3	1.95	1.99	0.92	2.29	3.76	-1.18	6.98	2.13
Price/Tangible Book Value High	35.87	11.98	1,869.4	13.85	-1,300.76	4.88	5.33	3.97	3.64	1.9	5.22	6.84	-1.94	11.83	6.7
Price/Tangible Book Value Low	1.55	2.18	591.58	2.65	-207.32	0.4	1.87	0.34	1.01	0.58	1.02	1.08	-0.8	0.6	0.8
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-2.7	-5.19	-2.3	-2.64	-0.77	-0.64	-1.74	-0.4	-1.48	-2.96	-1.62	-0.48	-1.05	-0.23	-0.33
Price/Cash Flow Average	-13.23	-6.74	-2.84	-4.73	-2.62	-1.64	-2.2	-1.83	-1.35	-2.3	-3.21	-1.21	-0.73	-2.02	-0.74
Price/Cash Flow High	-46.9	-15.44	-4.92	-7.87	-4.06	-6.48	-3.91	-3.73	-2.46	-4.74	-7.33	-2.21	-1.19	-3.42	-2.32
Price/Cash Flow Low	-2.02	-2.81	-1.56	-1.51	-0.65	-0.53	-1.38	-0.32	-0.68	-1.44	-1.43	-0.35	-0.49	-0.17	-0.28
Price/Free Cash Flow Average	-13.5	-6.84	-2.88	-4.74	-2.64	-1.65	-2.27	-1.9	-1.35	-2.31	-3.23	-1.23	-0.75	-2.05	-0.74
Price/Free Cash Flow High	-47.85	-15.67	-5	-7.89	-4.09	-6.54	-4.04	-3.86	-2.47	-4.76	-7.38	-2.23	-1.22	-3.48	-2.32
Price/Free Cash Flow Low	-2.06	-2.85	-1.58	-1.51	-0.65	-0.53	-1.42	-0.33	-0.68	-1.44	-1.44	-0.35	-0.5	-0.18	-0.28
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-12.95	-4.86	-2.21	-3.53	-2.2	-0.34	-1.26	-0.89	-0.49	0.31	-1.6	-0.4	-0.49	-1.43	-0.21
EV/EBITDA High	-48.18	-11.8	-3.96	-6.51	-3.65	-4.75	-2.83	-2.76	-1.41	-1.93	-5.48	-1.27	-0.88	-2.73	-1.82
EV/EBITDA Low	-1.23	-1.73	-1.13	-0.47	-0.22	0.67	-0.51	0.61	0.07	1.1	0.08	0.36	-0.3	0.27	0.26
EV/EBIT Average	-11.75	-4.59	-2.12	-3.39	-2.1	-0.32	-1.12	-0.88	-0.48	0.31	-1.59	-0.39	-0.49	-1.43	-0.21
EV/EBIT High	-43.7	-11.13	-3.81	-6.27	-3.49	-4.57	-2.5	-2.74	-1.4	-1.91	-5.45	-1.27	-0.88	-2.72	-1.8
EV/EBIT Low	-1.12	-1.63	-1.09	-0.45	-0.21	0.65	-0.45	0.61	0.07	1.09	0.08	0.36	-0.3	0.27	0.26
Last Price	264,000	444,000	222,000	92,700	22,200	3,660	4,110	465	675	624	198	51.3	83.1	8.97	2.95
High Price	4,590,000	1,320,000	474,000	276,000	116,700	36,900	9,210	4,320	1,125	999	894	237	94.5	133.5	20.59
Enterprise Value Average	74	40	24	33	18	3	15	10	7	-5	38	11	19	74	5
Enterprise Value High	275	97	43	61	30	43	34	32	20	29	131	36	34	141	41
Enterprise Value Low	7	14	12	4	2	-6	6	-7	-1	-17	-2	-10	12	-14	-6

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	4
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-93,552	-107,240.68	-114,528.13	-36,912.43	-28,642.42	-6,249.54	-2,577.49	-1,172.19	-549.03	-229.38	-129.59	-121.88	-95.16	-42.18	-8.73
Operating Income per Share	-103,139.56	-113,698.51	-118,999.26	-38,369.56	-29,909.91	-6,494.67	-2,908.05	-1,180.52	-554.22	-231.52	-130.4	-122.51	-95.64	-42.41	-8.81
Basic EPS, GAAP	-121,892.16	-121,303.03	-113,496.51	-31,952.79	-19,213.39	-6,433.2	-3,209.59	-1,568	-550.87	-228.55	-130.35	-135.18	-104.99	-36.52	-8.35
Basic EPS from Cont Ops	-121,892.16	-114,246.42	-113,496.51	-31,952.79	-19,213.39	-4,247.65	-2,899.78	-1,340.93	-550.87	-228.55	-130.35	-135.18	-104.99	-36.52	-8.35
Diluted EPS, GAAP	-121,892.16	-121,303.03	-113,496.51	-31,952.79	-19,213.39	-6,433.2	-3,209.59	-1,568	-550.87	-228.55	-130.35	-135.18	-104.99	-36.01	-8.35
Diluted EPS from Cont Ops	-121,892.16	-114,246.42	-113,496.51	-31,952.79	-19,213.39	-4,247.65	-2,899.78	-1,340.93	-550.87	-228.55	-130.35	-135.18	-104.99	-36.01	-8.35
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-97,870.33	-85,519.79	-96,364.67	-35,081.27	-28,716.71	-5,692.25	-2,356.28	-1,158.93	-457.09	-210.97	-121.96	-107.24	-79.48	-38.98	-8.86
Free Cash Flow per Basic Share	-99,811.49	-86,788.51	-97,920.59	-35,198.6	-28,921.15	-5,741.9	-2,430.4	-1,197.92	-458.05	-211.91	-122.72	-108.2	-81.6	-39.06	-8.87
Cash & Equivalents per Share	90,261.64	60,747.34	25,456.67	37,391.38	13,488.78	7,865.72	2,139.5	1,342.61	414.91	865.59	192.94	84.47	23.48	19.08	5.06
Book Value per Share	-516,066.51	-523,077.09	-537,468.83	-234,570.09	-225,897.52	-48,650.81	-18,034.92	-9,884.36	-4,365.44	-1,919.61	-815.43	-680.27	-497.71	-202.62	-103.18
Tangible Book Value per Share	127,961.66	110,167.7	253.56	19,928.85	-89.72	7,559.64	1,728.29	1,087.3	309.24	526.31	171.1	34.67	-48.69	11.28	3.07

Cellectar Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)